Global Oncology Academy
The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
211-225 of 474
Advancing Relapse Prediction in Pediatric AML Through Genomic MRD
On the Frontlines of AML/ALLAdvancing Relapse Prediction in Pediatric AML Through Genomic MRD
Ryan Quigley
Amanda Winters, MD, PhD
Understanding the Growing Burden of Early-Onset CRC
On the Frontlines of Colorectal CancerUnderstanding the Growing Burden of Early-Onset CRC
Ryan Quigley
Christopher Cann, MD
Decoding Co-Mutations in HR+, HER2- Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerDecoding Co-Mutations in HR+, HER2- Metastatic Breast Cancer
Abirami Sivapiragasam
Neighborhood Archetypes and Patient Outcomes in Pediatric ALL and AML
On the Frontlines of AML/ALLNeighborhood Archetypes and Patient Outcomes in Pediatric ALL and AML
Charles Turck, PharmD, BCPS, BCCCP
Lena Winestone, MD, MSHP
Improving BCC Screening in Childhood Cancer Survivors Through Risk Modeling
AudioAbstractsImproving BCC Screening in Childhood Cancer Survivors Through Risk Modeling
Ryan Quigley
Neoadjuvant Nivolumab With or Without Ipilimumab in Resectable CSCC
Project Oncology®Neoadjuvant Nivolumab With or Without Ipilimumab in Resectable CSCC
- advertisement
Cosibelimab Delivers Durable Responses in Advanced CSCC
Project Oncology®Cosibelimab Delivers Durable Responses in Advanced CSCC
Oncogenic Drivers in Never-Smokers with NSCLC
Project Oncology®Oncogenic Drivers in Never-Smokers with NSCLC
Apar Kishor Ganti, MD
Jobelle Baldonado, MD
Expanding Molecular Testing in Community NSCLC Care
Project Oncology®Expanding Molecular Testing in Community NSCLC Care
Apar Kishor Ganti, MD
Expanding Access to CAR T-Cell Therapy in R/R Myeloma Care
Project Oncology®Expanding Access to CAR T-Cell Therapy in R/R Myeloma Care
Brian P. McDonough, MD, FAAFP
Tara Graff, DO, MS
Surbhi Sidana, MD
Optimizing Care for Older Adults With FLT3-Mutated AML
On the Frontlines of AML/ALLOptimizing Care for Older Adults With FLT3-Mutated AML
Ryan Quigley
Nicholas Short, MD
- advertisement
Biomarker-Guided Treatment in ER+, HER2- Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerBiomarker-Guided Treatment in ER+, HER2- Metastatic Breast Cancer
Maxwell Llyod, MD
Ryan Quigley
Understanding Safety Profiles of ROS1 TKIs in Advanced Non-Small Cell Lung Cancer
AudioAbstractsUnderstanding Safety Profiles of ROS1 TKIs in Advanced Non-Small Cell Lung Cancer
Ryan Quigley
Modern Management of ROS1-Positive Non-Small Cell Lung Cancer
Project Oncology®Modern Management of ROS1-Positive Non-Small Cell Lung Cancer